A former hedge fund manager, Paul Mampilly has made a major milestone in the investment industry. His newsletter, Profits Unlimited, which was published by Banyan Hill Publishing, has registered more than 60,000 subscribers. This achievement has placed Profits Unlimited among the fastest growing newsletters in the world. Through the newsletter, Paul Mampilly shares investment insights with the main street Americans to help them make profitable investments. On a monthly basis, Mampilly mails an 8-page newsletter to his subscribers sharing information about one or two stocks. In addition, he monitors the performance of such investments on his website. As a financial advisor, Profits Unlimited does not invest capital for its investors. Subscribers have to purchase stocks in their own brokerage accounts. Presently, Mampilly’s open portfolio has 13 stocks that are up 18 percent, 21 percent, 31 percent, and 38 percent. Notably, out of the 13 stocks, 11 are profitable. This information was originally reported on PRNEwswire as outlined in this link.
About Paul Mampilly
Paul Mampilly is an accomplished investment expert who worked on Wall Street for 20 years. In addition, he has served prominent clients such as Deutsche Bank, Kinetics International and ING. While managing the Kinetics International Fund, Paul achieved significant milestones given that the funds that he was managing went up by 67 percent and 20 percent in 2009 and 2010 respectively. In an investment competition, launched by Templeton Foundation in 2009, Paul emerged the winner after generating a profit of 76 percent from a $50 million investment, which he increased to $88 million. He achieved this objective without shorting stocks considering that the financial crisis was at its peak.
Paul Mampilly has 25 years of experience in money management, especially in the bull market and bear market. Through his Profits Unlimited newsletter, he has generated a return of 23 percent in less than eight months. Paul’s investment ideas are a product of his unique propriety method that he has established over the years in trading and investments. This approach generates superior returns. Between October 2011 and December 2012, he recommended 29 stocks for the Palm Beach Letter. Within a year, the stocks were up by an average of 53 percent. All the stocks were profitable, but one. Some of these stocks include Yahoo +157 percent, Inter Parfums +117 percent and Boston Scientific +126 percent.
Keep Reading: https://dailyreckoning.com/dont-miss-the-biggest-biotech-market-ever/
Online reputation does not end with what you see online. It will involve more than that. You have to be willing to invest your money, time and energy to go towards maintaining a positive reputation for your brand. And, this is how you do it.
Maintaining your online reputation starts with monitoring. According to onlinereputationreviews.com, whenever you brand is mentioned, you have to be in the know. There are a variety of free and paid tools that can monitor your brands. Use them to find what other people and businesses are saying about you. It is only when you are aware of your online reputation situation, that you will be able to take the appropriate action.
Responding to Negative Reviews
It is impossible to make all your clients happy, every other time. Therefore, do not take negative reviews as a bad thing. If you have one or two of those, it is in fact good for business. People will know that your reviews are legit and that you don’t pay to have your business reviewed. However, the trick all lies in how you respond to the negative reviews. Be very professional about it, and even when your instincts tell you that attacking back is the best thing, do not go down that path. You will end up creating an even bigger crisis.
Social media is a great tool, used in maintaining online reputation. However, sometimes it can be the cause of even bigger problems. Being that there are so many people who use this platform to express themselves, you might find comments which make you angry. But this doesn’t call for an argument. If you want your business to stay afloat, the best thing is to avoid arguing with customers on social media. Or you will lose your credibility.
Invest in ORM
invest your time in bettering your online reputation. If you find that you don’t have the time or that this is too tasking, then employ the services of an ORM company. There are tons of professionals that are more than ready to help.
Cancer is the leading chronic killer disease in the world today. Scientists and medics have buried their heads in extensive research in pursuit of discovering its cure to no avail. Therefore, medical practitioners have opted to take up the prevention angle to reduce its increased dominance rather than curing. Eric Lefkoskyf as well has joined in the battle against cancer.Eric Lefkofsky graduated from Michigan University. He stands as both a co-founder and CEO of Tempus, a technological company that has developed an operating system to fight cancer. The Initiative was founded in 2015, but its effect in the health market was felt a year later 2016. He has also founded Lightbank that invests in disruptive technologies, Uptake Technologies, Mediaocean, Echo Global Logistics and InnerWorking. Besides, he has established the Lefkofsky Family Foundation, a charitable organization.
Eric Lefkofsky through Tempus works to give University of Chicago doctors’ data as a means to help treat breast cancer patients better. They in collaboration provide molecular sequencing and analysis to cancer specialists to create personalized treatment plans for cancer patients. Through the leadership of Eric, Tempus has offered to analyze data of over 1000 breast cancer patients as a means of helping medics and researchers unearth patterns that can forecast how patients will respond to administered treatment.
Tempus critically analyzed the health sector and realized that despite breast cancer being among the most common of cancers, there is a little reach to data about the millions of patients on record to have been afflicted with the disease. It has been a major setback to physicians in developing a specialized treatment to patients. Therefore, this has formed the basis for the partnership between the two institutions.Tempus is renowned for its mechanization and has considerably used machine learning and genomic sequencing to assist doctors to make more informed, personalized decisions on treatment. It also partners with other facilities all over America to use data in the fight against cancer. Its goal is to oversee the utilization of this data over time and help lead to better treatment and improved patient results.